These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16625812)

  • 1. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
    Khan A; Pawar G
    W V Med J; 2005; 101(6):258-60. PubMed ID: 16625812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B; Aslami B; Backes H
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
    Alrefai AH; Aburahma SK; Khader YS
    Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
    Verma A; Steele J
    Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin is a useful treatment in excessive drooling in saliva.
    Bhatia KP; Münchau A; Brown P
    J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):697. PubMed ID: 10577041
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
    Reid SM; Johnstone BR; Westbury C; Rawicki B; Reddihough DS
    Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful management of drooling with botulinum toxin A in neurologically disabled children.
    Ellies M; Rohrbach-Volland S; Arglebe C; Wilken B; Laskawi R; Hanefeld F
    Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What could predict effectiveness of Botulinum Toxin to treat drooling: a search for evidence of discriminatory factors on the level of body functions or structures.
    Erasmus CE; van Hulst K; Scheffer AR; van Limbeek J; van den Hoogen FJ; Rotteveel JJ; Jongerius PH
    Eur J Paediatr Neurol; 2012 Mar; 16(2):126-31. PubMed ID: 21783393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A and B for the reduction of hypersalivation in children with neurological disorders: a focus on effectiveness and therapy adherence.
    Schroeder AS; Kling T; Huss K; Borggraefe I; Koerte IK; Blaschek A; Jahn K; Heinen F; Berweck S
    Neuropediatrics; 2012 Feb; 43(1):27-36. PubMed ID: 22430158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
    Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
    Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
    Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hyperhidrosis and drooling with botulinum exotoxin.
    Odderson IR
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):837-54. PubMed ID: 14580041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative reduction of saliva production with botulinum toxin type B injection into the salivary glands.
    Turk-Gonzales M; Odderson IR
    Neurorehabil Neural Repair; 2005 Mar; 19(1):58-61. PubMed ID: 15673844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin: a deadly substance with great therapeutic effect.
    Holmes S
    Prof Nurse; 2003 Oct; 19(2):85-7. PubMed ID: 14593781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin use in neuro-rehabilitation to treat obstetrical plexus palsy and sialorrhea following neurological diseases: a review.
    Intiso D; Basciani M
    NeuroRehabilitation; 2012; 31(2):117-29. PubMed ID: 22951705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapeutic indications for botulinum toxins.
    Cordivari C; Misra VP; Catania S; Lees AJ
    Mov Disord; 2004 Mar; 19 Suppl 8():S157-61. PubMed ID: 15027069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ; Glasson C; O'Flaherty SJ
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
    Basciani M; Di Rienzo F; Fontana A; Copetti M; Pellegrini F; Intiso D
    Dev Med Child Neurol; 2011 Jun; 53(6):559-64. PubMed ID: 21413974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.